AMEH: Leadership/Comp Changes Reported in 8-K Filing
Ticker: ASTH · Form: 8-K · Filed: Jan 24, 2024 · CIK: 1083446
| Field | Detail |
|---|---|
| Company | Apollo Medical Holdings, INC. (ASTH) |
| Form Type | 8-K |
| Filed Date | Jan 24, 2024 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 3 min |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: executive-changes, corporate-governance, compensatory-arrangements
TL;DR
**AMEH filed an 8-K on Jan 24, 2024, indicating executive changes or compensation adjustments.**
AI Summary
Apollo Medical Holdings, Inc. (AMEH) filed an 8-K on January 24, 2024, reporting that the earliest event occurred on January 19, 2024. This filing indicates changes related to the departure or election of directors, appointment of officers, or compensatory arrangements for certain officers, as well as other events. While specific names or dollar amounts are not detailed in this summary, the filing signals potential shifts in leadership or executive compensation, which could impact the company's strategic direction and financial performance, making it relevant for current and prospective shareholders.
Why It Matters
Changes in leadership or executive compensation can signal shifts in company strategy or financial health, directly influencing investor confidence and stock valuation.
Risk Assessment
Risk Level: medium — The filing indicates changes in leadership or compensation, which can introduce uncertainty regarding future company direction and performance.
Analyst Insight
A smart investor would monitor subsequent filings or company announcements for specific details regarding the reported changes in leadership or compensation, as these specifics will determine the actual impact on the company's future performance and stock value.
Key Players & Entities
- Apollo Medical Holdings, Inc. (company) — the registrant filing the 8-K
- January 19, 2024 (date) — date of the earliest event reported
- January 24, 2024 (date) — date the 8-K was filed
- 001-37392 (other) — Commission File Number for Apollo Medical Holdings, Inc.
- AMEH (other) — Trading Symbol for Common Stock
- The Nasdaq Stock Market LLC (other) — exchange where Common Stock is registered
FAQ
What is the primary purpose of this 8-K filing by Apollo Medical Holdings, Inc.?
The primary purpose of this 8-K filing, as indicated by the 'ITEM INFORMATION', is to report 'Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers' and 'Other Events'.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing occurred on January 19, 2024, as stated under 'Date of report (Date of earliest event reported): January 19, 2024'.
What is the trading symbol and the exchange where Apollo Medical Holdings, Inc.'s common stock is registered?
Apollo Medical Holdings, Inc.'s common stock trades under the symbol AMEH and is registered on The Nasdaq Stock Market LLC, as detailed under 'Securities registered pursuant to Section 12(b) of the Act'.
What is the business address of Apollo Medical Holdings, Inc.?
The business address of Apollo Medical Holdings, Inc. is 1668 S. Garfield Avenue, 2nd Floor, Alhambra, California 91801, with a telephone number of (626) 282-0288.
What is the Central Index Key (CIK) for Apollo Medical Holdings, Inc.?
The Central Index Key (CIK) for Apollo Medical Holdings, Inc. is 0001083446, as found in the 'FILER: COMPANY DATA' section.
Filing Stats: 714 words · 3 min read · ~2 pages · Grade level 10.3 · Accepted 2024-01-24 08:30:26
Filing Documents
- tm243966d1_8k.htm (8-K) — 26KB
- 0001104659-24-006114.txt ( ) — 195KB
- ameh-20240119.xsd (EX-101.SCH) — 3KB
- ameh-20240119_lab.xml (EX-101.LAB) — 33KB
- ameh-20240119_pre.xml (EX-101.PRE) — 22KB
- tm243966d1_8k_htm.xml (XML) — 3KB
01 Other Events
Item 8.01 Other Events. On January 24, 2024, the Company announced its intention to change its corporate name to "Astrana Health Inc." and its ticker symbol on The Nasdaq Market LLC to "ASTH", effective on or about February 26, 2024.
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. APOLLO MEDICAL HOLDINGS, INC. Date: January 24, 2024 By: /s/ Brandon Sim Name: Title: Brandon Sim Chief Executive Officer and President